Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.
University of Manitoba, Faculty of Medicine, 260-727 McDermot Ave, Winnipeg, MB R3E 3P5. umcudmoj@cc.umanitoba.ca.
Jessica
J
Cudmore
Matthew
M
Seftel
Jeffrey
J
Sisler
Ryan
R
Zarychanski
D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D002955:Leucovorin; D008727:Methotrexate / Q000009:adverse effects*; D052016:Mucositis / Q000139:chemically induced; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011241:Prednisone / Q000627:therapeutic use; D013280:Stomatitis / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate